PubMed Health⌕ Search

Biomedical subjects

H Teshima

Publications and source records attributed to H Teshima.

At least 127 records · Page 7Linked to original sources
PubMed1988

Studies on the Fc receptors and masking substances on mouse and rat myeloma cells.

Mouse and rat myeloma cell lines showed little or no rosette formation with sheep erythrocytes (SRBC) coated with rabbit IgG (rabbit EA) but showed marked rosette formation after treatment with trypsin, pronase or neuraminidase. These cell lines showed no rosette formation with SRBC coated with mouse IgG (mouse EA): treatment with trypsin enabled the detection of rosettes among the mouse myeloma cell lines but not by the rat myeloma cells. The F(ab')2 fragment of the anti-Fc receptor II antibody blocked the formation of rosettes with rabbit EA by mouse myeloma cell lines after treatment with trypsin. Aggregated mouse IgG1 and IgG2b subclasses strongly inhibited the formation of rosettes with rabbit EA, whereas aggregated mouse IgG2a showed a marginal inhibitory effect. A large amount of mouse IgG2a, however, caused significant inhibition. Our results also revealed that aggregated mouse IgG could bind to the rat myeloma cell line. The Fc rosette forming abilities of the enzyme-treated mouse and rat myeloma cells became reduced after cultivation both in the presence and absence of FCS but not after cultivation in the presence of cycloheximide, suggesting that cell surface substances, which may be glycoprotein that incompletely mask Fc receptors, are produced by myeloma cells.

Animals↗
PubMed1988

[Effect of medical vagotomy on the CDDP induced nausea and vomiting evaluated by the chemotherapy-vomiting time (CV time)].

Twenty-eight patients with gynecologic malignancies receiving combination chemotherapy containing cisplatin (80 mg/m2) entered into a randomized controlled trial to evaluate the effect of medical vagotomy for acute cisplatin-induced emesis. Medical vagotomy consisted of 0.5 mg of atropine and 50 mg of hexamethonium bromide, and was injected three times at two hour intervals intramuscularly. A good antiemetic effect (no emesis during the 24 hours after cisplatin administration) was obtained in 40% (6/15) of patients with medical vagotomy but in 0% (0/13) in controlled cases. The time free of vomiting after cisplatin injection (CV time) was statistically prolonged in patients with medical vagotomy (805 +/- 563 min.) when compared with controlled cases (148 +/- 70 min.) (p less than 0.01). Toxicities with medical vagotomy were slight; mild hypotension and dimness of vision only. Individual differences in responding to medical vagotomy were investigated by the acetaminophen method, which showed that high and low responded cases were among these tested patients who had undergone medical vagotomy. In conclusion, medical vagotomy has an excellent antiemetic effect on acute cisplatin-induced emesis without notable side effects. If combined with other antiemetics, a much better antiemetic effect can be expected.

Acetaminophen↗
PubMed1988

[Relationship between peritoneal cytology and prognosis in endometrial carcinomas].

From 1971 to 1985, peritoneal cytologic examination was performed at the time of operation in 235 previously untreated patients with endometrial carcinoma. The relationship between the cytologic findings and prognoses by stage was investigated. The results were as follows: 1. In the peritoneal cytologic examination, 44 (18.7%) out of 235 cases were positive for cancer cells in all stages, 25 (14.5%) out of 173 cases in stage I, 7 (21.2%) out of 33 cases in stage II, and 8 (32.0%) out of 25 cases in stage III. 2. Among the 20 cases of stage I endometrial carcinoma that had no macroscopic metastasis and had positive peritoneal cytologic findings for cancer cells, 5- and 10-year cumulative survival rates were 94.7 and 94.7%, against 92.7% and 90.9% in cases with negative peritoneal cytology respectively. The recurrence rate in the same stage was 12.0% for positive cases, against 9.5% for negative cases. No significant differences between positive and negative cases were found. 3. In stages II and III, the difference between the survival rates for 9 cases which have positive peritoneal cytology without macroscopic peritoneal metastasis and 47 cases with negative peritoneal cytology were not statistically significant. 4. In endometrial carcinoma without macroscopic peritoneal metastasis, the appearance of cancer cells in peritoneal cytologic examination is not correlated with the prognosis.

Ascitic Fluid↗
PubMed1988

[Significance of preoperative diagnosis of endometrial carcinoma by angio-CT].

Angio computed tomography (CT) was performed in 87 previously untreated patients with endometrial carcinoma to study its clinical usefulness. All the patients subsequently underwent surgery and the angio CT findings were correlated with the surgical and pathologic findings. The results were as follows: 1. The tumor appeared as areas of low density in comparison with the surrounding myometrium after intraarterial infusion of contrast medium. 2. Angio CT proved to be useful in determining the depth of myometrial invasion. The myometrial invasion measured from the serosal surface in millimeters was assessed on angio CT. The CT findings were correlated well with pathologic findings. 3. Patients with intact myometrium greater than 10mm from the serosal surface assessed by angio CT had no nodal metastases. Angio CT provides a better display of cross-sectional uterine pathology than CT after intravenous infusion of contrast medium. The depth of myometrial invasion measured from the serosa on angio CT seems to be a useful prognostic factor in patients with endometrial carcinoma.

Female↗
PubMed1988

[Renal toxicity by intraperitoneal administration of CDDP].

Renal toxicity following intraperitoneal (ip) CDDP therapy after laparotomy in twenty patients with ovarian cancer was examined. Four patients had renal toxicity. Patients who received CDDP at a dose of 150 mg (2/2) had a statistically higher incidence of toxicity than those who received less than 100 mg (2/18) (p less than 0.05). Patients who underwent ip therapy on the same day as laparotomy had a statistically higher incidence of the toxicity (4/15) than those underwent it on the fourth day after (0/5) (p less than 0.05). Renal toxicity was revealed in the mean urine volume of 1,100 ml on the day of therapy, but the toxicity did not appeared in those with a mean urine volume of 2,131 ml, whose volume was statistically different (p less than 0.01). These data suggest maintenance of renal blood flow during CDDP treatment plays an important role in preventing renal toxicity even following ip therapy. By investigating preoperative laboratory data, it is seen that patients with FDP values higher than 32 micrograms/ml have a higher risk of renal toxicity.

Adult↗
PubMed1987

Effect of cisapride on the concentrations of beta-endorphinlike immunoreactivity and substance P-like immunoreactivity in the rat gastrointestinal tract.

Cisapride is a gastrointestinal prokinetic agent reported to be devoid of direct cholinergic effect from the myenteric plexus of the gut. The effect of cisapride (0.125, 0.5, 2mg/kg, i.p.) on the concentration beta-endorphin and substance P in rat gastrointestinal tract was studied. beta-Endorphinlike immunoreactivity contents were significantly increased in both mucosal and muscular layers of the entire gastrointestinal tract (from gastric body to rectum) of the rats treated with 2 mg/kg of cisapride. beta-Endorphinlike immunoreactivity contents were also increased in a part of the gastrointestinal tract of the rats treated with 0.125 or 0.5 mg/kg of cisapride. Substance P like immunoreactivity contents were significantly decreased in muscular layers of the rectosigmoid colon of the rats treated with 2 mg/kg of cisapride. This study suggests that the prokinetic effects of cisapride may relate to the contents of beta-endorphinlike immunoreactivity and substance P like immunoreactivity in gastrointestinal tract.

Animals↗
PubMed1987

[Advanced gastric cancer with DIC and multiple bone metastasis treated with surgical resection and chemotherapy].

Endoscopic examination of a 35-year-old patient complaining of tarry stool, palpitation and lumbago led to a diagnosis of gastric cancer of Borrmann type 4. Laboratory data and bone scintigraphy revealed findings of DIC and multiple bone metastasis. He was treated with continuous intravenous infusion of FOY, but laboratory data with DIC went from bad to worse. It was considered that resection of the tumor was effective for DIC, then total gastrectomy and partial transverse colonectomy were performed, and the patient recovered from DIC. For the multiple bone metastasis, he received chemotherapy using cisplatinum and mitomycin C, and subsequent bone scintigraphy showed a dramatic improvement. Doxorubicin and 5-fluorouracil controlled peritoneal dissemination of the cancer.

Adenocarcinoma↗
PubMed1987

[Clinical study of primary carcinoma of the fallopian tube: experience with 14 cases].

Between 1950 and 1986, 14 cases of primary carcinoma of the fallopian tube were treated and diagnosed at the Cancer Institute Hospital. These cases constituted 0.13% of the total number of gynecologic malignancies at the hospital during the period. The clinical/pathological findings and prognoses were described. Of the 14 cases, the average age was 56.0 years. The most frequent symptom was atypical genital bleeding, seen in 11 cases (79%). Massive watery discharge was seen in four cases (29%). In preoperative cytologic examination of vaginal smears, six cases (43%) were positive for cancer. All cases underwent operation as therapy. Postoperative irradiation, adjuvant chemotherapy, and/or second-or third- look operation was also used. Histopathologically, all materials were found to be adenocarcinoma. Four cases were well differentiated, seven were moderately differentiated, and three were poorly differentiated. Two patients with stage III and IV cancers died of the disease. Nine patients were still alive at the end of this study. The five-year survival rate was 57% (4/7). In stage I cancers, the five-year survival rate was 80% (4/5). The prognosis of stage I cancer patients was estimated as rather good.

Adenocarcinoma↗
PubMed1987

[Semi-quantitative evaluation of the intrapartum variable deceleration of the FHR pattern and its association with umbilical cord blood gas analysis].

Variable daceleration of FHR combined with no other abnormal pattern was semi-quantitatively evaluated to establish the diagnostic value of variable deceleration for fetal distress. FHR charts of 55 low risk vaginal deliveries by direct monitoring were analysed and the SDA (Sum of Dip Area) was calculated using the following equation: SDA = sigma Duration of dip (sec.) X Amplitude of dip (bpm.) X 10(-2) and correlation between SDA and umbilical cord blood gas analysis was obtained. A significant correlation was observed between SDA during labor (from 5 cm cervical dilation to delivery) and cord blood gas data. pHuv:r = -0.445 (p less than 0.005), PO2uv:r = -0.358 (p less than 0.01), BEuv:r = -0.538 (p less than 0.001), pHua:r = -0.441 (p less than 0.005), BEua:r = -0.463 (p less than 0.001). In 14 cases which showed prolonged deceleration (PD:more than 120 sec. in duration and below 100 bpm. in dip), excellent correlation was observed between the SDA of PD and pHuv:pHuv = 7.425-7.74 X 10(-4) SDA of PD (r = -0.756, p less than 0.005), whereas in 21 cases with severe variable deceleration (SVD:more than 60 sec. and recovered within 120 sec. in duration or below 60 bpm. in dip) no significant correlation was seen between the SDA of SVD and pHuv. These results suggest that the SDA value is helpful in evaluating variable deceleration during labor.

Female↗